Italian pharmaceutical glassmaker Bormioli Pharma is to acquire primary glass packaging group R&G Beteiligungs.
R&G is active in the business of plastic and glass primary packaging mainly used in the pharmaceutical industry. It employs approximately 270 people and operates two plants in Schleusingen and Altenfeld, both in Germany.
R&G registered a turnover of €25.6 m and an EBITDA equal to €Euro 4.1 m (representing 16.0% margin) in the fiscal year 2018.
Through this acquisition Bormioli Pharma said it would reinforce its presence in the German and Northern European markets, expand its current product range with complementary products and strengthen its manufacturing footprint and industrial competences.
The transaction is due to close during the fourth quarter of 2019.
Bormioli is owned by the Triton Fund IV.
